Fortress Biotech, Inc. Shares Outstanding (Cover Page)
Fortress Biotech, Inc. (FBIO) had Shares Outstanding (Cover Page) of 82.47 million shares as of 2020-05-07, per its 10-Q filed 2020-05-11.
Discontinued › Notes
dei:EntityCommonStockSharesOutstanding · last filed 2020-05-11
- 2020-05-07: Entity Common Stock, Shares Outstanding 82.47M shares.
- 2020-03-12: Entity Common Stock, Shares Outstanding 78.46M shares.
- 2019-11-08: Entity Common Stock, Shares Outstanding 70.78M shares.
- 2019-08-06: Entity Common Stock, Shares Outstanding 69.04M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2020-05-07 | 82.47M shares 10-Q · filed 2020-05-11 |
| 2020-03-12 | 78.46M shares 10-K · filed 2020-03-16 |
| 2019-11-08 | 70.78M shares 10-Q · filed 2019-11-12 |
| 2019-08-06 | 69.04M shares 10-Q · filed 2019-08-09 |
| 2019-05-08 | 65.23M shares 10-Q · filed 2019-05-10 |
| 2019-03-14 | 61.30M shares 10-K · filed 2019-03-18 |
| 2018-11-07 | 56.68M shares 10-Q · filed 2018-11-09 |
| 2018-08-09 | 54.34M shares 10-Q · filed 2018-08-09 |
| 2018-05-09 | 52.90M shares 10-Q · filed 2018-05-10 |
| 2018-03-13 | 51.34M shares 10-K · filed 2018-03-16 |
| 2017-11-09 | 50.66M shares 10-Q · filed 2017-11-09 |
| 2017-08-09 | 50.53M shares 10-Q · filed 2017-08-09 |
| 2017-05-10 | 50.33M shares 10-Q · filed 2017-05-10 |
| 2017-03-15 | 50.32M shares 10-K · filed 2017-03-16 |
| 2016-11-09 | 48.88M shares 10-Q · filed 2016-11-09 |
| 2016-08-09 | 48.67M shares 10-Q · filed 2016-08-09 |
| 2016-05-09 | 48.52M shares 10-Q · filed 2016-05-10 |
| 2016-03-15 | 48.52M shares 10-K · filed 2016-03-15 |
| 2015-11-09 | 47.13M shares 10-Q · filed 2015-11-09 |
| 2015-08-07 | 46.83M shares 10-Q · filed 2015-08-10 |
| 2015-05-11 | 46.82M shares 10-Q · filed 2015-05-11 |
| 2015-03-13 | 46.50M shares 10-K · filed 2015-03-16 |
| 2014-11-05 | 44.31M shares 10-Q · filed 2014-11-06 |
| 2014-08-06 | 44.31M shares 10-Q · filed 2014-08-11 |
| 2014-05-09 | 44.31M shares 10-Q · filed 2014-05-12 |
| 2014-03-12 | 44.09M shares 10-K · filed 2014-03-14 |
| 2013-10-30 | 35.61M shares 10-Q · filed 2013-11-01 |
| 2013-08-02 | 31.90M shares 10-Q · filed 2013-08-05 |
| 2013-05-06 | 28.05M shares 10-Q · filed 2013-05-09 |
| 2013-03-11 | 26.02M shares 10-K · filed 2013-03-18 |
| 2012-11-13 | 24.38M shares 10-Q · filed 2012-11-14 |
| 2012-08-07 | 24.38M shares 10-Q · filed 2012-08-08 |
| 2012-05-15 | 18.63M shares 10-Q · filed 2012-05-15 |
| 2012-03-20 | 18.60M shares 10-K · filed 2012-03-29 |
| 2011-11-10 | 7.03M shares 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |